Literature DB >> 19851860

High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation.

Caryl J Antalis1, Tyler Arnold, Tamkeen Rasool, Bonggi Lee, Kimberly K Buhman, Rafat A Siddiqui.   

Abstract

The specific role of dietary fat in breast cancer progression is unclear, although a low-fat diet was associated with decreased recurrence of estrogen receptor alpha negative (ER(-)) breast cancer. ER(-) basal-like MDA-MB-231 and MDA-MB-436 breast cancer cell lines contained a greater number of cytoplasmic lipid droplets compared to luminal ER(+) MCF-7 cells. Therefore, we studied lipid storage functions in these cells. Both triacylglycerol and cholesteryl ester (CE) concentrations were higher in the ER(-) cells, but the ability to synthesize CE distinguished the two types of breast cancer cells. Higher baseline, oleic acid- and LDL-stimulated CE concentrations were found in ER(-) compared to ER(+) cells. The differences corresponded to greater mRNA and protein levels of acyl-CoA:cholesterol acyltransferase 1 (ACAT1), higher ACAT activity, higher caveolin-1 protein levels, greater LDL uptake, and lower de novo cholesterol synthesis in ER(-) cells. Human LDL stimulated proliferation of ER(-) MDA-MB-231 cells, but had little effect on proliferation of ER(+) MCF-7 cells. The functional significance of these findings was demonstrated by the observation that the ACAT inhibitor CP-113,818 reduced proliferation of breast cancer cells, and specifically reduced LDL-induced proliferation of ER(-) cells. Taken together, our studies show that a greater ability to take up, store and utilize exogenous cholesterol confers a proliferative advantage to basal-like ER(-) breast cancer cells. Differences in lipid uptake and storage capability may at least partially explain the differential effect of a low-fat diet on human breast cancer recurrence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19851860     DOI: 10.1007/s10549-009-0594-8

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  67 in total

1.  Bioinformatics analysis of proteomic profiles during the process of anti-Thy1 nephritis.

Authors:  Yang Lu; Xiaoluan Liu; Suozhu Shi; Huabin Su; Xueyuan Bai; Guangyan Cai; Fuquan Yang; Zhensheng Xie; Yunping Zhu; Yanqiong Zhang; Shujia Zhang; Xiaofan Li; Shan Wang; Di Wu; Li Zhang; Jie Wu; Yuansheng Xie; Xiangmei Chen
Journal:  Mol Cell Proteomics       Date:  2011-12-07       Impact factor: 5.911

Review 2.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

3.  Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment.

Authors:  Steve Seung-Young Lee; Junjie Li; Jien Nee Tai; Timothy L Ratliff; Kinam Park; Ji-Xin Cheng
Journal:  ACS Nano       Date:  2015-02-16       Impact factor: 15.881

Review 4.  Diabetes, Obesity, and Breast Cancer.

Authors:  Chifei Kang; Derek LeRoith; Emily J Gallagher
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

5.  Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness.

Authors:  Shuhua Yue; Junjie Li; Seung-Young Lee; Hyeon Jeong Lee; Tian Shao; Bing Song; Liang Cheng; Timothy A Masterson; Xiaoqi Liu; Timothy L Ratliff; Ji-Xin Cheng
Journal:  Cell Metab       Date:  2014-03-04       Impact factor: 27.287

6.  Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification.

Authors:  Caryl J Antalis; Aki Uchida; Kimberly K Buhman; Rafat A Siddiqui
Journal:  Clin Exp Metastasis       Date:  2011-07-09       Impact factor: 5.150

7.  Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells.

Authors:  Dunja Sobot; Simona Mura; Marie Rouquette; Branko Vukosavljevic; Fanny Cayre; Eric Buchy; Grégory Pieters; Sébastien Garcia-Argote; Maike Windbergs; Didier Desmaële; Patrick Couvreur
Journal:  Mol Ther       Date:  2017-06-09       Impact factor: 11.454

Review 8.  Acyl-CoA:cholesterol acyltransferases (ACATs/SOATs): Enzymes with multiple sterols as substrates and as activators.

Authors:  Maximillian A Rogers; Jay Liu; Bao-Liang Song; Bo-Liang Li; Catherine C Y Chang; Ta-Yuan Chang
Journal:  J Steroid Biochem Mol Biol       Date:  2014-09-12       Impact factor: 4.292

9.  1α,25-dihydroxyvitamin D inhibits de novo fatty acid synthesis and lipid accumulation in metastatic breast cancer cells through down-regulation of pyruvate carboxylase.

Authors:  Tomasz Wilmanski; Kimberly Buhman; Shawn S Donkin; John R Burgess; Dorothy Teegarden
Journal:  J Nutr Biochem       Date:  2016-12-01       Impact factor: 6.048

10.  High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer.

Authors:  Baoying Yuan; Changshun Wu; Xingwen Wang; Dan Wang; Huiling Liu; Ling Guo; Xiang-An Li; Junqing Han; Hong Feng
Journal:  Tumour Biol       Date:  2015-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.